The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis

Journal of Investigative Dermatology

Volumn 123, Issue 6, 2004, Pages

  Nestle, Frank O ^a   Conrad, Curdin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 23; JANUS KINASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY; PROTEIN P40; PROTEIN P40 ANTIBODY; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; BACTERIAL INFECTION; CELL PROLIFERATION; CLINICAL TRIAL; COMMON COLD; CYTOKINE PRODUCTION; DRUG TARGETING; HEADACHE; HUMAN; INFECTION SENSITIVITY; INJECTION PAIN; KERATINOCYTE; LYMPHOCYTOPENIA; MYCOBACTERIOSIS; NONHUMAN; NOTE; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SIDE EFFECT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TREATMENT OUTCOME;

EID: 9744229972     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23488.x     Document Type: Note

References (11)

1. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-{alpha}. J Exp Med 199:731-736, 2004
2. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB: Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial. Lancet 357:1842-1847, 2001
3. Davidson A, Diamond B: Autoimmune diseases. N Engl J Med 345:340-350, 2001
4. Kupper TS: Immunologic targets in psoriasis. N Engl J Med 349:1987-1990, 2003
5. Lankford CS, Frucht DM: A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73:49-56, 2003
6. Lee E, Trepicchio WL, Oestreicher JL, et al: Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-130, 2004
7. Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB: Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349:2014-2022, 2003
8. Lew W, Bowcock AM, Krueger JG: Psoriasis vulgaris: Cutaneous lymphoid tissue supports T-cell activation and 'Type 1' inflammatory gene expression. Trends Immunol 25:295-305, 2004
9. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664-1675, 2004
10. Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity 19:641-644, 2003
11. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR: Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057, 1998